The new report titled ‘Global Human Microbiome Modulators Market’, published by Emergen Research, is methodically curated by our team of analysts, keeping readers’ understanding in mind, and includes a wide-ranging database of industry distribution. The report carefully investigates the present market scenario and the fundamental growth prospects. The report entails an organized database of the Human Microbiome Modulators market dynamics that helps market analysts estimate the global Human Microbiome Modulators market growth rate over the projected timeline. Therefore, the report, published by Emergen Research, is a detail-oriented compilation of the crucial aspects of the Human Microbiome Modulators market, including the key players’ product offerings, the wide application range of these products, the major market segments, leading market contenders, their company profiles, pricing strategies, production capacities, revenue generation schemes, technological advancements, and many others.

The global human microbiome modulators market size is expected to reach USD 8.15 Billion at a steady revenue CAGR of 16.5% in 2030, according to latest analysis by Emergen Research. Market revenue growth is primarily driven by factors such as increasing investments in healthcare infrastructure rising geriatric population around the world, increasing prevalence of chronic and acute diseases, rising burden of lifestyle-induced disorders such as high blood pressure, diabetes, and obesity, and rapid adoption of preventive medicine. Microbiome modulators are intended to inhibit protein fermentation and formation of toxic metabolites including NH3, amines, and phenolic, while promoting fermentation of carbohydrates and production of Short Chain Fatty Acids (SCFAs), or good metabolites. In addition, SCFAs fuel colonocytes, promote intestinal motility, absorb nutrients, maintain colonic pH, boost immune system, and have antineoplastic properties. For instance, on 24 March 2022, Prof Chris Barnes from UCL recommended establishment of an Institute of Microbiome Engineering (IME) with eight pillars.

These themes will explore physical and engineering problems underlying architecture of host-microbiota systems when combined with greater data sets and community standards for experimental studies. Another such instance includes allocation of over USD 44 million by the Australian Government, in the future competitiveness of Australian health and medical research through National Health and Medical Research Council. It is primarily aimed at funding international collaborations, postgraduate scholarships, research equipment as well as infrastructure. Aforementioned instances depict that increasing investments in research and healthcare infrastructure serves to build more awareness and interest in microbiome research, which in turn, drives human microbiome modulators market growth.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @

Competitive Landscape:

Furthermore, the report includes an in-depth analysis of the competitive landscape. The segment covers a comprehensive overview of the company profiles along with product profiles, production capacities, products/services, pricing analysis, profit margins, and manufacturing process developments. The report also covers strategic business measures undertaken by the companies to gain substantial market share. The report provides insightful information about recent mergers and acquisitions, product launches, collaborations, joint ventures, partnerships, agreements, and government deals.

Key Companies Profiled in the Report:

Bayer AG, DuPont de Nemours, Inc., Sanofi S.A., Procter & Gamble Company, Koninklijke DSM N.V., Probi AB, Immuron Ltd, BioGaia AB, Ingredion Incorporated, Yakult Honsha Co., Ltd.

Segments Covered in this report are:

  • Product Outlook (Revenue, USD Billion; 2019-2030)

    • Prebiotics and Dietary Supplements
    • Probiotics and Creams
    • Drugs
  • Application Outlook (Revenue, USD Billion; 2019-2030)

    • Infections
    • Neurological Disorders
    • Cancers
    • Dermatological
    • Gastrointestinal
    • Metabolic
  • Regional Outlook (Revenue, USD Billion; 2019-2030)

    • North America
      1. U.S.
      2. Canada
      3. Mexico
    • Europe
      1. Germany
      2. UK
      3. France
      4. BENELUX
      5. Rest of Europe
    • Asia Pacific
      1. China
      2. Japan
      3. South Korea
      4. India
      5. Rest of APAC
    • Latin America
      1. Brazil
      2. Rest of LATAM
    • MEA
      1. Saudi Arabia
      2. UAE
      3. Rest of MEA

Browse Full Report Description + Research Methodology + Table of Content + Infographics@

Regional Landscape section of the Human Microbiome Modulators report offers deeper insights into the regulatory framework, current and emerging market trends, production and consumption patterns, supply and demand dynamics, import/export, and presence of major players in each region.

The various regions analyzed in the report include:

North America (U.S., Canada)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now)@

Research Report on the Human Microbiome Modulators Market Addresses the Following Key Questions:

Who are the dominant players of the Human Microbiome Modulators market?

Which regional market is anticipated to have a high growth rate over the projected period?

What consumer trends and demands are expected to influence the operations of the market players in the Human Microbiome Modulators market?

What are the key growth drivers and restraining factors of the Human Microbiome Modulators market?

What are the expansion plans and strategic investment plans undertaken by the players to gain a robust footing in the market?

What is the overall impact of the COVID-19 pandemic on the Human Microbiome Modulators market and its key segments?

Request Customization as per your specific requirement@

Latest Published Reports by Emergen Research:


About Us:

At Emergen Research, we believe in advancing with technology. We are growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web:

Direct Line: +1 (604) 757-9756


Visit for More Insights:

Explore Our Custom Intelligence services | Growth Consulting Services